A股異動丨萬訊自控漲6.69% 北京推出機器人產業發展三年行動方案
格隆匯12月20日丨萬訊自控(300112.SZ)漲6.69%,報10.36元,總市值29.65億元。《北京市機器人產業創新發展行動方案(2019—2022年)》發佈,方案提出,培育發展醫療健康、特種、協作、倉儲物流機器人等重點產業方向,打造具有全球影響力的機器人產業創新策源地和應用示範高地,到2022年全市機器人產業收入超過120億元。萬訊自控專注於研發、生產和銷售技術先進的工業自動化儀器儀表產品,是行業內生產產品品種最多、型號較為齊全的企業之一,產品廣泛應用於鋼鐵、有色金屬、電力、建材、石化、化工、輕工業、水處理等行業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.